Search Details

Word: swansons (lookup in dictionary) (lookup stats)
Dates: during 1980-1989
Sort By: most recent first (reverse)


Usage:

Seniors will dominate the back line, with Andy Lauta at stopper, Sherm Swanson at sweeper, and Bill Champaigne at right fullback. The other wingback slot remains marginally open, with the smart money going on Matt Aaron...

Author: By Mark H. Doctoroff, | Title: Ivy Soccer: The Nucleus of Parity | 9/14/1981 | See Source »

...Douglas made his Broadway debut in 1928. In 1931 he married Actress Helen Gahagan, who later became a noted political activist and Congresswoman from California. After establishing himself as a suave, romantic leading man during the 1930s and 1940s by playing opposite such stars as Greta Garbo (Ninotchka), Gloria Swanson (Tonight or Never) and Joan Crawford (A Woman's Face), Douglas shifted to first-rate character portrayals in such films as Billy Budd (1962), The Americanization of Emily (1964) and I Never Sang for My Father (1970). Douglas, who had just completed his 77th film, Ghost Story, which...

Author: /time Magazine | Title: Milestones: Aug. 17, 1981 | 8/17/1981 | See Source »

...went public. Genentech was founded by Robert Swanson, another former partner, sand Biologist Herbert Boyer. Today, Swanson is the president of Genentech, while Perkins is the chairman. The initial $200,000 put into the firm has swelled into stock worth $40 million...

Author: /time Magazine | Title: Boom Time in Venture Capital | 8/10/1981 | See Source »

...extremely well. Today, after less than five years, Genentech probably has the best research facilities in the gene-splicing business (40 Ph.D.s, 65 technicians). It has produced and is testing half a dozen recombinant DNA products, including insulin, human growth hormone and various types of human interferon. Swanson gives Boyer the highest grades: "For an academic, he's got an incredible sense of what's important from a business standpoint...

Author: /time Magazine | Title: Science: Blue-Chips for a Biochemist | 3/9/1981 | See Source »

Boyer now draws only a consultant's fee for his Genentech work, but he has not exactly gone unrewarded. Like Swanson, he owns 925,000 shares of Genentech stock. Last October, when the stock shot up to $89 a share, he was briefly worth more than $80 million. Currently, with the stock at around $43, the figure is down to a mere $40 million or so. Watching the ebb and flow of this paper fortune, Boyer admits: "It's all a little unreal...

Author: /time Magazine | Title: Science: Blue-Chips for a Biochemist | 3/9/1981 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | Next